Screener

Deferred Revenue

Name: Novavax Deferred Revenue by Products & Services
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Novavax·Products & Services·1 segment·Rolls up to Deferred Revenue

Breakdown

Segment	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Transition Services	$40.2M	$42.6M	$21M	$10.7M	$8.6M	$2.2M	$2.5M	$900K
Total	$613.42M	$675.07M	$108.33M	$113.76M	$104.25M	$140.05M	$88.77M	$86.58M

Transition ServicesView metric